The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
Open accessAbstract
Rationale: Recent data suggest that a thrombogenic atrial substrate can cause stroke in the absence of atrial fibrillation. Such an atrial cardiopathy may explain some proportion of cryptogenic strokes. Aims: The aim of the ARCADIA trial is to test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in subjects with cryptogenic ischemic stroke and atrial cardiopathy. Sample size estimate: 1100 participants. Methods and design: Biomarker-driven, randomized, double-blind, active-control, phase 3 clinical trial conducted at 120 U.S. centers participating in NIH StrokeNet. Population studied: Patients ≥ 45 years of age with embolic stroke of undetermined source and evidence of atrial cardiopathy, defined as ≥ 1 of the following markers: P-wave terminal force >5000 µV × ms in ECG lead V 1, serum NT-proBNP > 250 pg/mL, and left atrial diameter index ≥ 3 cm/m 2 on echocardiogram. Exclusion criteria include any atrial fibrillation, a definite indication or contraindication to antiplatelet or anticoagulant therapy, or a clinically significant bleeding diathesis. Intervention: Apixaban 5 mg twice daily versus aspirin 81 mg once daily. Analysis: Survival analysis and the log-rank test will be used to compare treatment groups according to the intention-to-treat principle, including participants who require open-label anticoagulation for newly detected atrial fibrillation. Study outcomes: The primary efficacy outcome is recurrent stroke of any type. The primary safety outcomes are symptomatic intracranial hemorrhage and major hemorrhage other than intracranial hemorrhage. Discussion: ARCADIA is the first trial to test whether anticoagulant therapy reduces stroke recurrence in patients with atrial cardiopathy but no known atrial fibrillation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · cited 4×
“Antiplatelet drugs are the current standard for antithrombotic therapy in cases of ESUS.(18) However, anticoagulant drugs are substantially more effective than antiplatelet drugs in patients with AF,(19) and given the parallels between atrial cardiopathy and AF, it is likely that anticoagulation will also be superior…”
BackgroundInfluentialRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Derdeyn, C. P., Turan, T. N., Fiorella, D., Lane, B. F., Janis, L. S., Lutsep, H. L., Barnwell, S. L., Waters, M. F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105335 · Cited by 1,901
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Kasner, S. E., Benesch, C. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043033 · Cited by 1,744
Self-citationEmbolic strokes of undetermined source: the case for a new clinical construct
Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O'Donnell, M. J., Sacco, R. L., & Connolly, S. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70310-7 · Cited by 1,681
Atrial fibrillation in patients with cryptogenic stroke
Gladstone, D. J., Spring, M., Dorian, P., Panzov, V., Thorpe, K. E., Hall, J., Vaid, H., O'Donnell, M., Laupacis, A., Côté, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311376 · Cited by 1,276
Left Atrial Size and the Risk of Stroke and Death: The Framingham Heart Study
Benjamin, E. J., D’Agostino, R. B., Belanger, A. J., Wolf, P. A., & Levy, D. (1995) · Circulation · doi:10.1161/01.cir.92.4.835 · Cited by 1,055
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Hart, R. G., Sharma, M., Mundl, H., Kasner, S. E., Bangdiwala, S. I., Berkowitz, S. D., Swaminathan, B., Lavados, P., Wang, Y., Wang, Y., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802686 · Cited by 1,028
Pathak, R. K., Middeldorp, M. E., Lau, D. H., Mehta, A. B., Mahajan, R., Twomey, D., Alasady, M., Hanley, L., Antic, N. A., McEvoy, R. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.028 · Cited by 949
Innovative Interventional and Imaging Registries: Precision Medicine in Cerebrovascular Disorders
Liebeskind, D. S. (2015) · Interventional Neurology · doi:10.1159/000438773 · Cited by 608
Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update
Hart, R. G., Catanese, L., Perera, K. S., Ntaios, G., & Connolly, S. J. (2017) · Stroke · doi:10.1161/strokeaha.116.016414 · Cited by 553
Barnes, M. E., Miyasaka, Y., Seward, J. B., Gersh, B. J., Rosales, A. G., Bailey, K. R., Petty, G. W., Wiebers, D. O., & Tsang, T. S. M. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.8.1008 · Cited by 288
Left Atrial Size and the Risk of Ischemic Stroke in an Ethnically Mixed Population
Di Tullio, M. R., Sacco, R. L., Sciacca, R. R., & Homma, S. (1999) · Stroke · doi:10.1161/01.str.30.10.2019 · Cited by 248
Self-citationLeft Atrial Enlargement and Stroke Recurrence: The Northern Manhattan Stroke Study
Yaghi, S., Moon, Y. P., Mora-McLaughlin, C., Willey, J. Z., Cheung, K., Di Tullio, M. R., Homma, S., Kamel, H., Sacco, R. L., & Elkind, M. S. V. (2015) · Stroke · doi:10.1161/strokeaha.115.008711 · Cited by 218
Self-citationPrevalence of Nonstenosing, Complicated Atherosclerotic Plaques in Cryptogenic Stroke
Freilinger, T. M., Schindler, A., Schmidt, C., Grimm, J., Cyran, C., Schwarz, F., Bamberg, F., Linn, J., Reiser, M., Yuan, C., et al. (2012) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.01.012 · Cited by 207
Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
Amarenco, P., Davis, S., Jones, E. F., Cohen, A. A., Heiss, W.-D., Kaste, M., Laouénan, C., Young, D., Macleod, M., Donnan, G. A., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.004251 · Cited by 197
Electromechanical dysfunction of the left atrium associated with interatrial block
Goyal, S. B., & Spodick, D. H. (2001) · American Heart Journal · doi:10.1067/mhj.2001.118110 · Cited by 191
Folsom, A. R., Nambi, V., Bell, E. J., Oluleye, O. W., Gottesman, R. F., Lutsey, P. L., Huxley, R. R., & Ballantyne, C. M. (2013) · Stroke · doi:10.1161/strokeaha.111.000173 · Cited by 171
Kamel, H., Soliman, E. Z., Heckbert, S. R., Kronmal, R. A., Longstreth, W. T., Nazarian, S., & Okin, P. M. (2014) · Stroke · doi:10.1161/strokeaha.114.006364 · Cited by 167
Self-citationGeisler, T., Poli, S., Meisner, C., Schreieck, J., Zuern, C. S., Nägele, T., Brachmann, J., Jung, W., Gahn, G., Schmid, E., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493016681019 · Cited by 163
Perros, F., Ranchoux, B., Izikki, M., Bentebbal, S., Happé, C. M., Antigny, F., Jourdon, P., Dorfmüller, P., Lecerf, F., Fadel, É., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.11.050 · Cited by 152
Kamel, H., O’Neal, W. T., Okin, P. M., Loehr, L. R., Alonso, Á., & Soliman, E. Z. (2015) · Annals of Neurology · doi:10.1002/ana.24482 · Cited by 146
Self-citationElectrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study
Kamel, H., Hunter, M. D., Moon, Y. P., Yaghi, S. R., Cheung, K., Tullio, M. R. D., Okin, P. M., Sacco, R. L., Soliman, E. Z., & Elkind, M. S. V. (2015) · Stroke · doi:10.1161/strokeaha.115.009989 · Cited by 136
Self-citationCushman, M., Judd, S. E., Howard, V. J., D, B. M. K. M., Gutiérrez, O. M., Jenny, N. S., Ahmed, A., Thacker, E. L., & Zakai, N. A. (2014) · Stroke · doi:10.1161/strokeaha.114.004712 · Cited by 135
Effect of pravastatin on cerebral infarcts and white matter lesions
ten Dam, V. H., van den Heuvel, D. M. J., van Buchem, M. A., Westendorp, R. G. J., Bollen, E. L. E. M., Ford, I., de Craen, A. J. M., & Blauw, G. J. (2005) · Neurology · doi:10.1212/01.wnl.0000161844.00797.73 · Cited by 113
Longstreth, W. T., Kronmal, R. A., Thompson, J. L. P., Christenson, R. H., Levine, S. R., Gross, R., Brey, R. L., Buchsbaum, R., Elkind, M. S. V., Tirschwell, D., et al. (2013) · Stroke · doi:10.1161/strokeaha.112.675942 · Cited by 112
Self-citationGupta, A. K., Gialdini, G., Lerario, M. P., Baradaran, H., Giambrone, A. E., Navi, B. B., Marshall, R. S., Iadecola, C., & Kamel, H. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002012 · Cited by 104
Self-citationZhao, W., Hill, M. D., & Palesch, Y. (2015) · Statistical Methods in Medical Research · doi:10.1177/0962280212436447 · Cited by 87
Self-citationEffect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study
O'Donnell, M. J., Eikelboom, J. W., Yusuf, S., Diener, H., Hart, R. G., Smith, E. E., Gladstone, D. J., Sharma, M., Dias, R., Flaker, G., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.019 · Cited by 72
The effect of left atrial histology and dimension on P wave morphology
Scott, C. C., Leier, C. V., Kilman, J. W., Vasko, J. S., & Unverferth, D. V. (1983) · Journal of Electrocardiology · doi:10.1016/s0022-0736(83)80086-7 · Cited by 32
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Self-citationAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
Diener, H.-C., Sacco, R. L., Easton, J. D., Granger, C. B., Bernstein, R. A., Uchiyama, S., Kreuzer, J., Cronin, L., Cotton, D., Grauer, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813959 · Cited by 824
Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke
Montaner, J., Ramiro, L., Simats, A., Tiedt, S., Makris, K., Jickling, G. C., Debette, S., Sanchez, J.-C., & Bustamante, A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0350-6 · Cited by 330
Metadata
- Authors
- Kamel, H., Longstreth, W., Tirschwell, D. L., Kronmal, R. A., Broderick, J. P., Palesch, Y. Y., Meinzer, C., Dillon, C., Ewing, I., Spilker, J. A., Di Tullio, M. R., Hod, E. A., Soliman, E. Z., Chaturvedi, S., Moy, C. S., Janis, S., & Elkind, M. S.
- Venue
- International Journal of Stroke
- Publisher
- SAGE Publications
- Published
- 2018-09-10
- Volume
- 14
- Issue
- 2
- Pages
- 207-214
- ISSN
- 1747-4930 (ISSN-L)
- 1747-4949
- OpenAlex
- W2891629937
- Cited by
- 380
- References
- 36
- FWCI
- 29.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.